ArticleDiscover oncology2025

Prolonged neoadjuvant hormonal therapy enhances IL-17 A/STAT3-mediated inflammation in prostate cancer.

Yirui Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.